CLINICAL_TRIALS trial_result · 2016-03-02

Clinical Trial Update: A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. [Phase 2]

A completed Phase 2 trial of AUY922 (ganetespib) in non-small cell lung cancer after two prior chemotherapies has posted results (2016-03-02).

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Non-small-cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-02